BIT Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

BIT Capital’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,500	Closed	–	–	149
2023 Q3	$0	Hold	7,500	–	–	﹤0.01%	167
2023 Q2	$288K	Hold	7,500	–	–	0.03%	99
2023 Q1	$174K	Sell	7,500 -5,400	-42%	-$129K	0.03%	113
2022 Q4	$338K	Buy	+12,900	New	+$286K	0.07%	102

BIT Capital's KDNY Position: Q4 2023 in Review

BIT Capital sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q4 2023, closing a stake of 7,500 shares.

BIT Capital first reported a position in KDNY in Q4 2022 and held it in 4 quarters. The position peaked at $338K in Q4 2022. 1 fund tracked by Wall St. Rank holds KDNY as of Q4 2023.

BIT Capital reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
BIT Capital sold 7,500 Chinook Therapeutics, Inc. Common Stock shares in Q4 2023.
BIT Capital first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
BIT Capital's Chinook Therapeutics, Inc. Common Stock position peaked at $338K in Q4 2022.
1 fund tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2023.

Based on BIT Capital's 13F filing for Q4 2023, filed 12 Feb 2025.